• Home
    • About Us
  • KRIYA Conference
  • Resources
    • Find a Provider
    • FDA Workgroup
    • Reading List
    • Videos & Podcasts
    • Lectures
    • Articles
    • Books
    • Music
    • Hotlines
    • Low Fee Psychotherapy
  • For Clinicians
    • Guidelines
    • Trainings
    • Networking Events
    • Supply List
    • Forms
    • Clinical Scales
    • COVID
  • Contact Us
    • Mailing List
    • Newsletters
  • Site Map

KRIYA Ketamine Research Institute

Schedule 2016

Saturday (11/12/16)

9:15 am = Parking lot opens
9:30 am – 10:00 am = Check-in for CME & Coffee
10:15 am – 12:30 pm = Morning Session:

Raquel Bennett, Psy.D. (San Mateo, CA)
– Topic: Paradigms of ketamine treatment: medical, psychological, and spiritual
Steven Levine, M.D. (Princeton, NJ)
– Topic: “The primest time for ketamine” – what has happened in the past year with respect to ketamine treatment, and where we are headed in the future
Stephen Hyde, M.D. (Tasmania, Australia)
– Topic: Using sublingual ketamine at home to treat depression

12:30 pm – 1:15 pm = Lunch

1:15 pm – 3:30 pm = Early Afternoon Session:

Steven Mandel, M.D. (Los Angeles, CA)
– Topic: Using IV ketamine to treat depression in an anesthesiology practice
Brian Johns, M.D. (Robbinsdale, MN)
– Topic: Ketamine in place of maintenance ECT for patients with severe depression; benzodiazepines reduce ketamine’s effectiveness
Evgeny Krupitsky, M.D./Ph.D. (St. Petersburg, Russia)
– Topic: Ketamine-assisted therapy for patients with opiate addiction

3:30 pm – 3:45 pm = Snack Break

3:45 pm – 6:00 pm = Late Afternoon Session:

Patrick Marshalek, M.D. (Morgantown, WV) & Scott Pollard, M.D. (Cody, WY)
– Topic: Treating patients with trans-buccal ketamine in a university clinic setting, and integrating ketamine treatment with other kinds of psychiatric care
Angelo De Gioannis, M.D. (Brisbane, Australia)
– Topic: Ketamine as a “transformative medicine,” and augmenting ketamine treatment with other medications
Jennifer Winegarden, D.O. (Livonia, MI)
– Topic: Using ketamine in a hospice setting for pain and depression

Sunday (11/13/16)

9:15 am = Parking lot opens
9:30 am – 10:00 am = Check-in for CME & Coffee
10:15 am – 12:30 pm = Morning Session:

Raquel Bennett, Psy.D. (San Mateo, CA)
– Long-term ketamine treatment from the patient’s perspective
Jon Berner, M.D./Ph.D. (Seattle, WA)
– Topic: Ten year retrospective report on patients who use IM ketamine at home
Enrique Abreu, D.O. (Portland, OR)
– Topic: Demonstration of “Ketamine Monitor” – cellphone-based tracking program to monitor patients’ moods during the course of ketamine treatment

12:30 pm – 1:15 pm = Lunch

1:15 pm – 3:30 pm = Early Afternoon Session:

Francoise Bourzat, M.A. (San Francisco, CA)
– Topic: Using high dose IM ketamine treatment for spiritual work and personal growth
Phil Wolfson, M.D. & Julane Andries, M.F.T. (San Anselmo, CA)
– Topic: Ketamine-assisted psychotherapy using IM ketamine, and maintenance therapy using oral lozenges
Terrence Early, M.D. (Santa Barbara, CA)
– Topic: Ketamine-assisted therapy for patients with PTSD and/or attachment difficulties

3:30 pm – 3:45 pm = Snack Break

3:45 pm – 6:00 pm = Late Afternoon Session:

Carl Bonnett, M.D. (San Antonio, TX)
– Topic: Ketamine and the mental health of veterans
Jason Wallach, Ph.D. (Philadelphia, PA)
– Topic: Pharmacology of Arylcyclohexylamines (PCP, Ketamine, MXE)
KRIYA Institute
– Topic: Looking to the future: where do we want to go from here?

Copyright © 2025 · KRIYA Ketamine Research Institute